76 related articles for article (PubMed ID: 22119929)
1. Molecular imaging of breast tumors using a near-infrared fluorescently labeled clusterin binding peptide.
Filfil R; Paul-Roc B; Cantin C; Iqbal U; Tolkatchev D; Vinogradova A; Xu P; Ni F; O'Connor-McCourt MD; Lenferink AE
Int J Cancer; 2012 Sep; 131(5):E681-92. PubMed ID: 22119929
[TBL] [Abstract][Full Text] [Related]
2. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
4. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
[TBL] [Abstract][Full Text] [Related]
6. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
7. Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging.
Kim HY; Wang X; Wahlberg B; Edwards WB
Bioconjug Chem; 2014 Jul; 25(7):1311-22. PubMed ID: 24898150
[TBL] [Abstract][Full Text] [Related]
8. Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes.
Bremer C; Tung CH; Bogdanov A; Weissleder R
Radiology; 2002 Mar; 222(3):814-8. PubMed ID: 11867806
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.
Hara T; Bhayana B; Thompson B; Kessinger CW; Khatri A; McCarthy JR; Weissleder R; Lin CP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2012 Jun; 5(6):607-15. PubMed ID: 22698530
[TBL] [Abstract][Full Text] [Related]
10. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide.
Kelly K; Alencar H; Funovics M; Mahmood U; Weissleder R
Cancer Res; 2004 Sep; 64(17):6247-51. PubMed ID: 15342411
[TBL] [Abstract][Full Text] [Related]
11. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
12. A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
Yang X; Zhang F; Luo J; Pang J; Yan S; Luo F; Liu J; Wang W; Cui Y; Su X
Oncol Rep; 2016 Jul; 36(1):79-89. PubMed ID: 27221614
[TBL] [Abstract][Full Text] [Related]
13. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
Lee JY; Kim HJ; Rho SB; Lee SH
Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
[TBL] [Abstract][Full Text] [Related]
14. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
15. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
Ma G; Cai H; Gao L; Wang M; Wang H
World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
[TBL] [Abstract][Full Text] [Related]
16. Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies.
Napp J; Dullin C; Müller F; Uhland K; Petri JB; van de Locht A; Steinmetzer T; Alves F
Int J Cancer; 2010 Oct; 127(8):1958-74. PubMed ID: 20473895
[TBL] [Abstract][Full Text] [Related]
17. A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells.
Nowakowski GS; Dooner MS; Valinski HM; Mihaliak AM; Quesenberry PJ; Becker PS
Stem Cells; 2004; 22(6):1030-8. PubMed ID: 15536193
[TBL] [Abstract][Full Text] [Related]
18. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.
Becker A; Hessenius C; Licha K; Ebert B; Sukowski U; Semmler W; Wiedenmann B; Grötzinger C
Nat Biotechnol; 2001 Apr; 19(4):327-31. PubMed ID: 11283589
[TBL] [Abstract][Full Text] [Related]
19. Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.
Themelis G; Harlaar NJ; Kelder W; Bart J; Sarantopoulos A; van Dam GM; Ntziachristos V
Ann Surg Oncol; 2011 Nov; 18(12):3506-13. PubMed ID: 21509632
[TBL] [Abstract][Full Text] [Related]
20. SPECT and near-infrared fluorescence imaging of breast cancer with a neuropilin-1-targeting peptide.
Feng GK; Liu RB; Zhang MQ; Ye XX; Zhong Q; Xia YF; Li MZ; Wang J; Song EW; Zhang X; Wu ZZ; Zeng MS
J Control Release; 2014 Oct; 192():236-42. PubMed ID: 25058570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]